Home / Inspections / 1299022

FDA Inspection 1299022 — Biomat USA, Inc

Biomat USA, Inc — FEI 2071424

The FDA completed an inspection of Biomat USA, Inc on January 7, 2026 in Orange, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 7, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Orange, CA (United States)

Facility

Other inspections at this facility

  • 1102124 (NAI Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 944013 (NAI Thu Sep 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 767582 (NAI Mon Feb 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources